glp-1 agonists medications New Guidelines for Type 2 Diabetes in 2025 Are Serious Anesthesia Risks of

Boratynski PJ, Zielinska-Blajet M, Skarzewski J

GLP-1 Agonists: Optimizing Therapy Across Clinical Scenarios (1.5 hours) CE/CME Course #: 25-396 Review clinical guidance on optimizing use of GLP-1 receptor agonists (RAs) for managing type 2 diabetes and weight loss, as well as their role in cardiovascular and kidney diseases

While the study missed its primary endpoint it reported a reduction in heavy alcohol consumption among participants with obesity (Klausen Jensen Mller)

Constipation: While less common than diarrhea, some patients report constipation as a side effect

Respondents were clear about who they think these medications are really for